Needle-free Injection System Market Opportunity Analysis, Outlook, Growth By Top Players Antares Pharma, Inc., Endo International plc, Portal Instruments, Inc., Zogenix, PharmaJet, Bioject Medical Technologies Inc., Medical International Technology, Inc.,

Biologicals are increasingly launched and prescribed to treat disease such as GI tract disease (ulcerative colitis and Crohn’s disease), central nervous system associated disease (multiple sclerosis and Alzheimer’s disease), and cancer. Other factors such as increasing incidence of communicable diseases caused due to conventional needle, increasing geriatric population worldwide who need palliative care, and growing awareness about safe injection practices are also expected to drive growth of needle-free injection system market.

However, per unit cost of needle-free injection may restrain the market growth. As this system is relatively new and do not have wider penetration yet, its use is still very limited. Moreover, developing economies where vaccine need is increasing with growing population would find it difficult to access this product.

Download PDF Brochure@ https://www.coherentmarketinsights.com/insight/request-pdf/1681

Needle-free injection system is continuously expanding its market footprint on account of various factors. Increasing incidence of needle associated injuries and needle phobia amongst children and adults is expected to drive growth of needle-free injection system market. According to a study published in Behavioral Neurology, 2014, around 3-4 % of the world population faces needle phobia. This impacts their hospital or clinic visits, as they avoid visiting such facilities due to fear of exposure to needles. Needle phobia also impacts the vaccination amongst children, as most of them perceives injecting vaccine as a painful procedure. According to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination every year worldwide, most of which required injecting drug with a needle syringe system. Increasing demand for vaccines and other biologic products is another factor boosting growth of the needle-free injection system market. According to the World Health Organization (WHO) 2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million children are unvaccinated leading to death of 2-3 million children every year. Chronic disease such as diabetes often needs daily dose of insulin, which has to be administered through pain needles. This may lead to lack of adherence to treatment due to lack of confidence to self-inject insulin. Increasing research on biologics and biosimilar is another factor expected to fuel growth of the market.

Self-medication becomes convenient with needle-free injection due to increased confidence amongst user for self-medication and therefore it offers better treatment adherence and improved quality of life. Needle-free injection eliminates needle phobia, as medication is administered through system such as jet injection system to the skin. Moreover, needle-free injection system allows drug delivery of even viscous drug, which is difficult with conventional needle syringe system. Needle-free injection system also allows efficient delivery of biological drugs, which are unstable due to risk of protein denaturation. This is possible as needle-free injection system maintains biological integrity and it does not have silicon oil or tungsten material in its primary container. It is reusable and delivers drug faster, as compared to conventional needle syringe system due to hair size jet stream through which drug is administered.

Some of the key players operating in the market include Antares Pharma, Inc., Endo International plc, Portal Instruments, Inc., Zogenix, PharmaJet, Bioject Medical Technologies Inc., Medical International Technology, Inc., PenJet Corporation, INJEX Pharma AG, National Medical Products Inc., Valeritas, Inc., European Pharma Group, and Crossject SA.

Collaborations amongst companies to develop the needle-free injection system would also boost growth of needle-free injection system market. For instance, in November 2017, Takeda Pharmaceutical and Portal Instruments entered into collaboration agreement to develop the needle-free drug delivery device with the Takeda Pharmaceuticals biologic medicines for hepatitis, Crohn's disease etc.

Request for Customization@ https://www.coherentmarketinsights.com/insight/request-customization/1681

Market Taxonomy

On the basis of product type:

Prefilled
Fillable
On the basis of delivery site:

Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors
On the basis of product lifecycle:

Disposable
Reusable
On the basis of technology:

Jet-based needle free injector
Spring-based needle free injector
Laser-powered needle free injector
On the basis of application:

Vaccine and other biologic product delivery
Insulin Delivery
Others
On the basis of end user:

Hospitals & Clinics
Home based care
On the basis of geography:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1681

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.